Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,550 | -4,300 | -27,240 | 15,050 | 11,210 |
| Depreciation Amortization | 800 | 140 | 940 | -38,640 | -23,960 |
| Accounts receivable | N/A | N/A | -3 | N/A | N/A |
| Other Working Capital | 0 | -2,550 | -7,350 | -4,850 | -2,190 |
| Other Operating Activity | -7,200 | -2,860 | 13,673 | 5,020 | -70 |
| Operating Cash Flow | $-15,950 | $-9,570 | $-19,980 | $-23,420 | $-15,010 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -30 | -7 | -80 | -60 | -50 |
| Net Acquisitions | 0 | 0 | 110 | 0 | 0 |
| Other Investing Activity | 0 | 0 | -10 | 0 | 0 |
| Investing Cash Flow | $-30 | $-7 | $20 | $-60 | $-50 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 23,708 | N/A | N/A |
| Other Financing Activity | 12,440 | 12,440 | -8 | 8,910 | 1,390 |
| Financing Cash Flow | $12,440 | $12,440 | $23,700 | $8,910 | $1,390 |
| Exchange Rate Effect | -100 | -310 | -70 | -110 | -510 |
| Beginning Cash Position | 43,200 | 43,200 | 39,520 | 39,520 | 39,520 |
| End Cash Position | 39,550 | 45,750 | 43,200 | 24,820 | 25,330 |
| Net Cash Flow | $-3,640 | $2,550 | $3,680 | $-14,690 | $-14,180 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,950 | -9,570 | -19,980 | -23,420 | -15,010 |
| Capital Expenditure | N/A | N/A | -85 | N/A | N/A |
| Free Cash Flow | -15,950 | -9,570 | -20,065 | -23,420 | -15,010 |